0RF
(2S)-2-(4-chlorophenyl)-1-{4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl}-3-(propan-2-ylamino)propan-1-one
Find entries where: 0RF
is present as a standalone ligand in 1 entries
Chemical Component Summary | |
---|---|
Name | (2S)-2-(4-chlorophenyl)-1-{4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl}-3-(propan-2-ylamino)propan-1-one |
Identifiers | (2S)-2-(4-chlorophenyl)-1-[4-[(5R,7R)-5-methyl-7-oxidanyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one |
Formula | C24 H32 Cl N5 O2 |
Molecular Weight | 458.00 |
Type | NON-POLYMER |
Isomeric SMILES | C[C@@H]1C[C@H](c2c1c(ncn2)N3CCN(CC3)C(=O)[C@H](CNC(C)C)c4ccc(cc4)Cl)O |
InChI | InChI=1S/C24H32ClN5O2/c1-15(2)26-13-19(17-4-6-18(25)7-5-17)24(32)30-10-8-29(9-11-30)23-21-16(3)12-20(31)22(21)27-14-28-23/h4-7,14-16,19-20,26,31H,8-13H2,1-3H3/t16-,19-,20-/m1/s1 |
InChIKey | GRZXWCHAXNAUHY-NSISKUIASA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 64 |
Chiral Atom Count | 3 |
Bond Count | 67 |
Aromatic Bond Count | 12 |
Drug Info: DrugBank
DrugBank ID | DB11743 |
---|---|
Name | Ipatasertib |
Groups | investigational |
Description | Ipatasertib has been used in trials studying the treatment of Cancer, Neoplasms, Solid Cancers, Breast Cancer, and Gastric Cancer, among others. |
Synonyms | Ipatasertib |
Categories |
|
CAS number | 1001264-89-6 |
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 24788740 |
ChEBI | CHEBI:95089 |
ChEMBL | CHEMBL2177390 |
Pharos | CHEMBL2177390 |